Edwards EVOQUE Transcatheter Tricuspid Valve Replacement: Pivotal Clinical Investigation of Safety and Clinical Efficacy using a Novel Device Short Title: TRISCEND II Pivotal Trial

Brief description of study

The objectives of this clinical study are to evaluate the safety and effectiveness of the Edwards EVOQUE tricuspid valve replacement system with OMT compared to OMT alone in the treatment of patients with at least severe tricuspid regurgitation (TR).a


Clinical Study Identifier: s20-01862
ClinicalTrials.gov Identifier: NCT04482062
Principal Investigator: Mathew R. Williams.


If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.